Xintela AB (XINT)

Currency in SEK
0.389
+0.029(+8.06%)
Closed·
XINT Scorecard
Full Analysis
Stock price movements are quite volatile
XINT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.3710.404
52 wk Range
0.2040.700
Key Statistics
Prev. Close
0.36
Open
0.371
Day's Range
0.371-0.404
52 wk Range
0.204-0.7
Volume
248.39K
Average Volume (3m)
538.07K
1-Year Change
32.35%
Book Value / Share
-0.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XINT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Xintela AB Company Profile

Xintela AB (publ), a biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy. The company’s stem cell products include XSTEM, which is in Phase I/IIa clinical development for the treatment of knee osteoarthritis, as well as in clinical study for the treatment of difficult-to-heal leg ulcers, acute respiratory distress syndrome, and other indications; and EQSTEM that is in preclinical development for the treatment of joint disease in horses. It is also developing antibody-based cancer therapies, such as TARG9 and TARG10, which are in preclinical study for the treatment of triple-negative breast cancer and the brain tumor glioblastoma. It has an agreement with Region Östergötland for GMP process development of cell therapy for burn patients. Xintela AB (publ) was incorporated in 2009 and is based in Lund, Sweden.

Compare XINT to Peers and Sector

Metrics to compare
XINT
Peers
Sector
Relationship
P/E Ratio
−6.2x−9.6x−0.5x
PEG Ratio
−0.16−0.190.00
Price/Book
−14.4x6.6x2.6x
Price / LTM Sales
59.1x42.3x3.3x
Upside (Analyst Target)
-10.5%43.5%
Fair Value Upside
Unlock6.4%6.9%Unlock

Earnings

Latest Release
May 23, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

XINT Income Statement

FAQ

What Stock Exchange Does Xintela Trade On?

Xintela is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Xintela?

The stock symbol for Xintela is "XINT."

What Is the Xintela Market Cap?

As of today, Xintela market cap is 259.00M.

What Is Xintela's Earnings Per Share (TTM)?

The Xintela EPS (TTM) is -0.06.

When Is the Next Xintela Earnings Date?

Xintela will release its next earnings report on 28 Aug 2025.

From a Technical Analysis Perspective, Is XINT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Xintela Stock Split?

Xintela has split 1 times.

How Many Employees Does Xintela Have?

Xintela has 13 employees.

What is the current trading status of Xintela (XINT)?

As of 07 Aug 2025, Xintela (XINT) is trading at a price of 0.39, with a previous close of 0.36. The stock has fluctuated within a day range of 0.37 to 0.40, while its 52-week range spans from 0.20 to 0.70.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.